Skip to content

Clinical trials

Phase 1 Stress Disorders, Post-Traumatic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stress Disorders, Post-Traumatic Phase: Phase 1 Clear all

120 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20063
20075
20087
20096
20103
20115
20127
20131
20144
20155
20165
20174
20182
20197
20204
20218
20225
20236
20247
20259
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Recruiting12
Unknown status10
Not yet recruiting8
Withdrawn8
Terminated5
Active, not recruiting3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
VA Office of Research and Development11
Yale University9
Emory University4
Soul Medicine Institute4
Johns Hopkins University3
US Department of Veterans Affairs3
University of California, San Francisco3
Baylor College of Medicine2
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.2
Mclean Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stress Disorders, Post-Traumatic120
Anxiety Disorders15
Major Depressive Disorder11
Alcoholism8
Wounds and Injuries6
Combat Disorders5
Substance-Related Disorders5
Mental Disorders4
Bipolar Disorder3
Depressive Disorder, Treatment-Resistant3

Trials

Showing 1 to 25 of 120. Each trial links to its page on Pharma Observatory.

20 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.